Zagreb, 16 July 2026 – Provectus Capital Partners ("Provectus") has signed a share purchase agreement under which Zavarovalnica Triglav, the Triglav Group's parent company, will acquire a 49% stake in Arsano Medical Group Croatia ("Arsano" or the "Group") from Provectus. Following completion of the transaction, Provectus will remain the majority shareholder alongside Triglav, with both shareholders committed to supporting the Group's long-term development. The transaction is subject to customary closing conditions, including approval by the relevant competition authorities.
Triglav is one of the leading insurance and financial groups in Southeast Europe, with a strong strategic focus on the development of health insurance. Building on the strong platform developed by Provectus and Arsano's management team, the new shareholder partnership brings together complementary capabilities in healthcare delivery. Together, the shareholders share a long-term ambition to support continued investment in clinical excellence, innovation and digitalisation, broaden access to high-quality healthcare services and contribute to the continued evolution of Croatia's private healthcare sector.
Provectus invested in Polyclinic Aviva in September 2021 with the ambition of building a leading private healthcare group in Croatia by partnering with exceptional medical professionals and selectively bringing together complementary healthcare providers under a shared strategic vision. Since then, Arsano Medical Group has grown into a diversified healthcare group comprising seven polyclinics and specialty hospitals across multiple medical disciplines. During Provectus' ownership, the Group’s revenues grew from €3 million to approximately €30 million through a combination of acquisitions and organic growth, while its workforce expanded to more than 430 professionals.
Andrej Slapar, President of the Management Board of Zavarovalnica Triglav commented:
" Over the past few years, Arsano Medical Group has demonstrated its ability to combine excellence in healthcare with entrepreneurial dynamism. We are pleased to become a co-owner of the Group and, together with our partners – the private equity firm Provectus Capital Partners and the management of Arsano Medical Group – to be able to support its continued growth and thereby help create new opportunities to strengthen high-quality private healthcare services for the benefit of both patients and policyholders. Together, we bring complementary expertise, experience and resources, providing a strong foundation for achieving these objectives and creating added value for all our stakeholders."
Igor Čičak, Managing Partner and CEO at Provectus Capital Partners commented:
"Croatia's fragmented private healthcare market offered an opportunity to build a leading healthcare group through a disciplined buy-and-build strategy in partnership with outstanding founders, medical professionals and management. The progress achieved over the past five years has validated our investment thesis and established a strong foundation for continued growth. This transaction represents an important milestone in that journey, marking the beginning of a new phase in Arsano Medical Group's development. We are pleased to welcome Triglav as a shareholder whose expertise complements the capabilities developed within the Group and look forward to remaining the majority shareholder alongside Triglav as we continue supporting the Group's long-term growth."
Boris Rivić, CEO of Arsano Medical Group, added:
"Over the past five years, Arsano Medical Group has grown from a single polyclinic into Croatia’s leading private healthcare group while remaining focused on what matters most: delivering high-quality care to our patients. That progress has been made possible through the dedication of our medical professionals and employees, together with the support of Provectus as a long-term partner. We are pleased to welcome Triglav as a new shareholder. Its expertise in health insurance and healthcare management complements our clinical capabilities and creates new opportunities to continue investing in our people, facilities, technology and medical excellence. Together with Provectus, we look forward to building on the strong foundations established over the past five years and continuing to deliver outstanding care for our patients."